This study aimed to systematically review the available literature on “quality of life” (QoL) or “health-related quality of life” (HRQoL) in Turner syndrome (TS) patients and to analyze the relations among height, puberty, and the use of growth hormone (GH) and the QoL of TS patients.
An electronic bibliographic search was conducted through the PubMed, Embase, Bireme, Scopus, and Web of Science databases. The main terms were “Quality of Life” and “Turner syndrome.”
Among the databases, 559 articles were found; after the selection process, 13 studies were selected. A quality assessment was conducted, and all the studies were of high quality. Eight well-known QoL questionnaires were used, and the selected studies presented factors that may be related to the QoL of TS patients, such as height, puberty, and GH use. However, a more detailed understanding of which factors are associated with the QoL of TS patients is still needed, which may be due to the lack of specific QoL instruments involving important aspects related to TS.
The QoL of TS patients appears to be compromised, but existing data regarding the relations among height, puberty, and GH and QoL are still controversial. Although these factors should be carefully considered in TS patients, it was not possible to determine whether they have a significant relation with the QoL of TS patients.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Baena, N., Vigan, C., Cariati, E., Clementi, M., Stoll, C., Caballín, M., et al. (2004). Turner syndrome: Evaluation of prenatal diagnosis in 19 European registries. American Journal of Medical Genetics, 129(A), 16–20. https://doi.org/10.1002/ajmg.a.30092.
Jacobs, P., Dalton, P., James, R., Mosse, K., Power, M., & Robinson, D. (1997). Turner syndrome: A cytogenetic and molecular study. Annals of Human Genetics, 61, 471–483.
Nielsen, J., & Wohlert, M. (1990). Sex chromosome abnormalities found among 34,910 newborn children: results from a 13-year incidence study in Arhus, Denmark. Birth Defects Original Article Series, 26(4), 209–223.
Sybert, V. P., & McCauley, E. (2004). Turner’s syndrome. New England Journal of Medicine, 351, 1227–1238.
Bondy, C. A. (2006). Turner’s syndrome and X chromosome - based differences in disease susceptibility. Gender Medicine, 3(1), 18–30.
Donaldson, M. D. C., Gault, E. J., Tan, K. W., & Dunger, D. B. (2006). Optimising management in Turner syndrome: from infancy to adult transfer. Archives of Disease in Childhood, 91, 513–520.
Power, T., Langlois, N. E. I., & Byard, R. W. (2014). The forensic implications of Turner’s syndrome. Journal of Forensic Sciences, 59(3), 671–675.
Wang, S., Yang, L., Li, J., & Mu, Y. (2015). Concurrent insulinoma with mosaic Turner syndrome: A case report. Experimental and Therapeutic Medicine, 9, 801–804.
Gawlik, A., & Malecka-Tendera, E. (2014). Treatment of Turner’s syndrome during transition. European Journal of Endocrinology, 170, R57-R74.
Giordano, R., Forno, D., Lanfranco, F., Manieri, C., Ghizzoni, L., & Ghigo, E. (2011). Metabolic and cardiovascular outcomes in a group of adult patients with Turner’s syndrome under hormonal replacement therapy. European Journal of Endocrinology, 164, 819–826.
Levitsky, L. L., Luria, A. H. O., Hayes, F. J., & Lin, A. E. (2015). Turner syndrome: Update on biology and management across the life span. Current Opinion in Endocrinology, Diabetes and Obesity, 22(1):65–72.
Lucaccioni, L., Wong, S. C., Smyth, A., Lyall, H., Dominiczak, A., Ahmed, S. F., et al. (2015). Turner syndrome—issues to consider for transition to adulthood. British Medical Bulletin, 113, 45–58.
Hong, D., Kent, J. S., & Kesler, S. (2009). Cognitive profile of Turner syndrome. Developmental Disabilities Research Reviews, 15(4), 270–278.
Mccauley, E., Feuillan, P., Kushner, H., & Ross, J. L. (2001). Psychosocial development in adolescents with Turner syndrome. Journal of Developmental and Behavioral Pediatrics, 22(6), 360–365.
Marzelli, M. J., Hoeft, F., Hong, D. S., & Reiss, A. L. (2011). Neuroanatomical spatial patterns in Turner syndrome. NeuroImage, 55, 439–447.
Cohen, J. S., & Biesecker, B. B. (2010). Quality of life in rare genetic conditions: A systematic review of the literature. American Journal of Medical Genetics, 152A(5), 1136–1156. https://doi.org/10.1002/ajmg.a.33380.
The WHOQOL Group. (1995). The World Health Organization Quality of Life assessment (WHOQOL): Position paper from the World Health Organization. Social Science and Medicine, 41, 1403–1409.
Hoxha, P., Babameto-Laku, A., Vyshka, G., Gjoka, K., Minxuri, D., Myrtaj, E., et al. (2015). Turner syndrome in Albania and the efficacy of its treatment with growth hormone. Journal of Pediatric Endocrinology and Metabolism, 28(11–12), 1227–1234.
Fekkes, M., Kamphuis, R. P., Ottenkamp, J., Verrips, E., Vogels, T., & Kamphuis, M. (2001). Health-related quality of life in young adults with minor congenital heart disease. Psychology and Health, 16, 239–251.
Dołega, Z., Jeż, W., & Irzyniec, T. (2014). The cohort effect in studies related to differences in psychosocial functioning of women with Turner syndrome. Endokrynologia Polska, 65(4), 287–294.
Ros, C., Alobid, I., Balasch, J., Mullol, J., & Castelo-Branco, C. (2013). Turner’s syndrome and other forms of congenital hypogonadism impair quality of life and sexual function. American Journal of Obstetrics and Gynecology, 208(6), 484.e1–484.e6.
Cardoso, G., Daly, R., Haq, N. A., Hanton, L., Rubinow, D. R., Bondy, C. A., et al. (2004). Current and lifetime psychiatric illness in women with Turner syndrome. Gynecological Endocrinology, 19(6), 313–319.
Moher, D., Liberati, A., Tetzlaff, J., & Altman, D. G. (2009). Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. BMJ, 339, b2535.
Fowkes, F. G. R., & Fulton, P. M. (1991). Critical appraisal of published research: introductory guidelines. BMJ, 302, 1136–1140.
Fjermestad, K. W., Naess, E. E., Bahr, D., & Gravholt, C. H. (2016). A 6-year follow-up survey of health status in middle-aged women with Turner syndrome. Clinical Endocrinology, 85, 423–429. https://doi.org/10.1111/cen.13068.
Freriks, K., Verhaak, C. M., Sas, T. C. J., Menke, L. A., Wit, J. M., Otten, B. J., et al. (2015). Long-term effects of oxandrolone treatment in childhood on neurocognition, quality of life and social - emotional functioning in young adults with Turner syndrome. Hormones and Behavior, 69, 59–67.
Nadeem, M., & Roche, E. F. (2014). Health-related quality of life in Turner syndrome and the influence of key features. Journal of Pediatric Endocrinology and Metabolism, 27(3–4), 283–289.
Taback, S. P., & Van Vliet, G. (2011). Health-related quality of life of young adults with Turner syndrome following a long-term randomized controlled trial of recombinant human growth hormone. BMC Pediatrics, 11, 49.
Lasaite, L., Lašiene, D., & Lašas, L. (2010). Cognition, emotions and quality of life in Lithuanian girls with Turner syndrome after growth hormone therapy discontinuation. Journal of Pediatric Endocrinology and Metabolism, 23(5), 443–450.
Amundson, E., Boman, U. W., Barrenas, M. L., Bryman, I., & Landin-Wilhelmsen, K. (2010). Impact of growth hormone therapy on quality of life in adults with Turner syndrome. Journal of Clinical Endocrinology and Metabolism, 95, 1355–1359.
Naess, E. E., Bahr, D., & Gravholt, C. H. (2010). Health status in women with Turner syndrome—a questionnaire study on health status, education, work participation and aspects of sexual functioning. Clinical Endocrinology, 72, 678–684. https://doi.org/10.1111/j.1365-2265.2009.03715.x.
Zuckerman-Levin, N., Frolova-Bishara, T., Militianu, D., Levin, M., Aharon-Peretz, J., & Hochberg, Z. (2009). Androgen replacement therapy in turner syndrome: A pilot study. Journal of Clinical Endocrinology and Metabolism, 94(12), 4820–4827.
Bannink, E. M., Raat, H., Mulder, P. G. H., & Keizer-schrama, S. M. P. F. M. (2006). Quality of life after growth hormone therapy and induced puberty in women with Turner syndrome. The Journal of Pediatrics, 148, 678–684.
Carel, J. C., Elie, C., Ecosse, E., Tauber, M., Léger, J., Sylvie, & Cabrol (2006). Self-esteem and social adjustment in young women with Turner syndrome- influence of pubertal management and sexuality: Population- based cohort study. Journal of Clinical Endocrinology and Metabolism, 91(80), 2972–2979.
Carel, J. C., Ecosse, E., Bastie-Sigeac, I., Cabrol, S., Tauber, M., Leger, J., et al. (2005). Quality of life determinants in young women with Turner’s syndrome after growth hormone treatment: Results of the StaTur population-based cohort study. Journal of Clinical Endocrinology and Metabolism, 90, 1992–1997.
Boman, U. W., Bryman, I., & Moller, A. (2004). Psychological well-being in women with Turner syndrome: Somatic and social correlates. Journal of Psychosomatic Obstetrics and Gynecology, 25, 211–219.
Boman, U. W., Bryman, I., Halling, K., & Moller, A. (2001). Women with Turner syndrome: Psychological well-being, self-rated health and social life. Journal of Psychosomatic Obstetrics Gynecology, 22(2), 113–122.
Borenstein, M., Hedges, L. V., Higgins, J. P. T., & Rothstein, H. R. (2009). When does it make sense to perform a meta-analysis?, in introduction to meta-analysis. Chichester: Wiley.
Higgins, J.P.T, & Green, S. (Eds.)., Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from http://handbook.cochrane.org.
Okada, Y. (1994). The quality of life of Turner women in comparison with grown-up GH-deficient women. Endocrine Journal, 41(4), 345–354.
This study was funded by Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq). Doctoral Fellowship Number 140965/2015-7.
Conflict of interest
All authors declare that they have no conflict of interest.
This article does not contain any studies with human participants or animals performed by any of the authors.
About this article
Cite this article
Reis, C.T., de Assumpção, M.S., Guerra-Junior, G. et al. Systematic review of quality of life in Turner syndrome. Qual Life Res 27, 1985–2006 (2018). https://doi.org/10.1007/s11136-018-1810-y
- Quality of life
- Turner syndrome
- Body height
- Growth hormone